$55.80
-1.52-2.65%
At Close: -
$55.80
00.00%
After Hours: Sep 20, 4:04 PM EDT
15 minutes delayed
Keros Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Keros Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-1.25 | $-1.23 | -1.63 % |
Mar 2024 | 2024-05-08 | $-1.21 | $-1.34 | 9.70 % |
Dec 2023 | 2024-02-28 | $-1.34 | $-1.37 | 2.19 % |
Sep 2023 | 2023-11-06 | $-1.33 | $-1.35 | 1.48 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2023 | 2023-08-07 | $0 | $220.00K | -100.0 % |
Mar 2023 | 2023-05-04 | $0 | $220.00K | -100.0 % |
Dec 2022 | 2023-03-03 | $0 | $860.00K | -100.0 % |
Keros Therapeutics (KROS) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-1.25, which missed the estimate of $-1.23.
The Actual Revenue was $37K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.